1. Electrochemical aptasensor for human osteopontin detection using a DNA aptamer selected by SELEX
   Sofia G. Meirinho et al, 2017, Analytica Chimica Acta CrossRef
2. Osteopontin gene polymorphism association with milk traits and its expression analysis in milk of riverine buffalo
   Sidra Manzoor et al, 2017, Trop Anim Health Prod CrossRef
3. Osteopontin splice variants and polymorphisms in cancer progression and prognosis
   Marco Antonio Briones-Orta et al, 2017, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
4. RNA sequencing identifies novel markers of non-small cell lung cancer.
   Seon-Sook Han et al, 2014, Lung Cancer CrossRef
5. Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.
   Tatiana M Tilli et al, 2012, Prostate CrossRef
6. Chlamydia trachomatis induces an upregulation of molecular biomarkers podoplanin, Wilms' tumour gene 1, osteopontin and inflammatory cytokines in human mesothelial cells.
   Anna De Filippis et al, 2017, Microbiology (Reading) CrossRef
7. Role of osteopontin in the pathophysiology of cancer
   Lalita A. Shevde et al, 2014, Matrix Biology CrossRef
8. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
   Tianxiang Ge et al, 2015, Med. Oncol. CrossRef
9. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
   T M Tilli et al, 2012, Exp. Mol. Pathol. CrossRef
10. Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay
    Agnieszka Horala et al, 2017, IJMS CrossRef
11. Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial
    Lina Prasmickaite et al, 2015, Cancer Immunol Immunother CrossRef
12. Osteopontin as a therapeutic target for cancer
    Monalisa Bandopadhyay et al, 2014, Expert Opinion on Therapeutic Targets CrossRef
13. Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis
    Yulan Liu et al, 2015, PLoS ONE CrossRef
14. Time and Circumstances: Cancer Cell Metabolism at Various Stages of Disease Progression.
    Georg F Weber, 2016, Front Oncol CrossRef
15. An osteopontin promoter polymorphism is associated with aggressiveness in breast cancer
    DIVYA RAMCHANDANI et al, 2013 CrossRef
16. The role of osteopontin in the progression of solid organ tumour.
    Hailin Zhao et al, 2018, Cell Death Dis CrossRef
17. The effect of in vitro photodynamic therapy on increase of osteopontin and heat shock protein 70 expression in squamous cell and colon carcinoma
    Marta Wozniak et al, 2018, IEEE J. Select. Topics Quantum Electron. CrossRef
18. Serum angiogenesis profile in gestational trophoblastic neoplasm using multiplex immunoassay
    Paulina Banach et al, 2018, Life Sciences CrossRef
19. Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis
    Kinga Walaszek et al, 2018, Br J Cancer CrossRef
20. The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis.
    Francisco Villanueva et al, 2019, J Cell Physiol CrossRef
21. RNA blood levels of osteopontin splice variants are cancer markers
    Franz Hartung et al, 2013, SpringerPlus CrossRef
22. OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase
    Chengcheng Hao et al, 2019, Sci Rep CrossRef
23. Plasma levels of osteopontin from birth to adulthood
    Nasenien Nourkami-Tutdibi et al, 2020, Pediatr Blood Cancer CrossRef
24. Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer
    Isabel J. Dionísio de Sousa et al, 2020, Diagnostics CrossRef
25. Tumor-Derived Osteopontin Reprograms Normal Mammary Fibroblasts to Promote Inflammation and Tumor Growth in Breast Cancer
    Yoray Sharon et al, 2015, Cancer Res CrossRef
26. The Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer Microenvironment.
    Casimiro Gerarduzzi et al, 2020, Cancer Res CrossRef
27. Increased Tenascin C, Osteopontin and HSP90 Levels in Plasmatic Small Extracellular Vesicles of Pediatric ALK-Positive Anaplastic Large Cell Lymphoma: New Prognostic Biomarkers?
    Federica Lovisa et al, 2021, Diagnostics CrossRef
28. Review of novel tissue-based biomarkers for prostate cancer: towards personalised and targeted medicine
    Ernest Osei et al, 2021, J Radiother Pract CrossRef
29. Osteopontina, una proteína involucrada en la progresión tumoral, y su participación en el desarrollo del carcinoma colorrectal.
    Daniel Becerra et al, 2019, Rev Cienc Biomed CrossRef
30. Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
    Mohammad Kamalabadi-Farahani et al, 2022, BMC Res Notes CrossRef
31. Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis
    Piotr Ziółkowski et al, 2022, Breast Cancer Res CrossRef
32. Osteopontin and Ki-67 expression in World Health Organization graded canine meningioma
    Janina Janssen et al, 2023, Journal of Comparative Pathology CrossRef
33. Meta-analysis of Osteopontin splice variants in cancer
    Yu An et al, 2023, BMC Cancer CrossRef
34. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma
    Ti Yang et al, 2023, Front. Oncol. CrossRef
35. SIGNIFICANCE OF OSTEOPONTIN FOR PREDICTING AGGRESSIVENESS OF PROSTATE CANCER
    N. Lukianova et al, 2023, Exp. oncol. CrossRef
36. null
    Alpana Kumari et al, 2024 CrossRef